| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 85,9 k € | +123.7% | -362,5 k € | -3868.1% | -9,1 k € | -117.4% | 52,5 k € | -79.0% | 250,0 k € | -32.1% | 368,0 k € | -68.8% | 1,2 M € | +3.5% | 1,1 M € | +47.5% | 773,5 k € | -10.7% | 866,4 k € | |
| EBITDA | 32,6 k € | +107.8% | -418,1 k € | -665.2% | -54,6 k € | -309.7% | 26,1 k € | -86.6% | 195,0 k € | -22.7% | 252,3 k € | -47.3% | 478,5 k € | -3.4% | 495,5 k € | +37.8% | 359,5 k € | -37.0% | 570,9 k € | |
| Operating profit | 32,6 k € | +107.8% | -418,1 k € | -665.2% | -54,6 k € | -309.7% | 26,1 k € | -86.6% | 195,0 k € | +127.7% | 85,7 k € | -82.1% | 478,5 k € | -3.4% | 495,5 k € | +37.8% | 359,5 k € | -37.0% | 570,9 k € | |
| Profit/loss | 31,2 k € | +107.4% | -419,4 k € | -645.1% | -56,3 k € | -479.6% | 14,8 k € | -89.6% | 143,3 k € | +100.8% | 71,4 k € | -78.1% | 326,4 k € | -4.5% | 341,8 k € | +42.7% | 239,5 k € | -36.2% | 375,6 k € | |
| Equity | -230,5 k € | +11.9% | -261,7 k € | -266.0% | 157,7 k € | -26.3% | 213,9 k € | +7.4% | 199,1 k € | +20.1% | 165,9 k € | -22.7% | 214,5 k € | -68.8% | 688,1 k € | +98.7% | 346,4 k € | -14.9% | 406,8 k € | |
| Total assets | 180,0 k € | -26.3% | 244,4 k € | +18.2% | 206,8 k € | -27.9% | 286,7 k € | -28.9% | 403,0 k € | -8.2% | 438,8 k € | -72.4% | 1,6 M € | +49.8% | 1,1 M € | +2.0% | 1,0 M € | +34.7% | 772,9 k € | |
| Cash | 14,0 k € | -64.4% | 39,5 k € | +36.3% | 29,0 k € | -65.0% | 82,8 k € | -35.4% | 128,1 k € | +93.9% | 66,1 k € | +21.3% | 54,5 k € | +1367.3% | 3,7 k € | -98.1% | 191,9 k € | -49.0% | 376,4 k € | |
| Debts | 410,6 k € | -18.9% | 506,1 k € | +930.8% | 49,1 k € | -32.5% | 72,7 k € | -64.3% | 203,9 k € | -25.3% | 272,9 k € | -80.2% | 1,4 M € | +268.2% | 373,6 k € | -46.2% | 694,7 k € | +91.8% | 362,1 k € | |
| Staff | 0,8 | 0,8 | 0,6 | 0,5 | 0,7 | 1,2 | 11,8 | 11,9 | 7,8 | 5,2 | ||||||||||
Private limited company with a balanced profile. Cash position declining (-64.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PLANIMED is a Private limited company incorporated in 2012. Its main activity is: Other human health activities. Its registered office is in Seraing. It employs on average 0,8 ETP workers (FTE).
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette